Real World Evidence Solutions Market by Component, Therapeutic Area, End User - Global Forecast to 2023 - ResearchAndMarkets.com

DUBLIN--()--The "Real World Evidence Solutions Market by Component, Therapeutic Area, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global real-world evidence market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% during the forecast period.

The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs). However, the reluctance to rely on real-world studies and the lack of universally accepted methodological standards for data collection are restraining the growth of this market.

On the basis of component, the real world evidence market is segmented into data sets and services. The services segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is mainly due to the rising need to convert data into actionable evidence, growing need to reduce drug development delays, and availability of large amounts of healthcare data are the major factors driving market growth in this segment.

Based on end user, the real-world evidence (RWE) market is broadly segmented into pharmaceutical & medical device companies, healthcare providers, healthcare payers, and other end users (academic institutions, patient advocacy groups, and health technology assessment agencies).

The pharmaceutical & biopharmaceutical companies segment is the fastest-growing segment in the real world evidence market during the forecast period. The rising demand to assess comparative effectiveness of drugs in actual, real-world use and the value or economic impact from the use of new or existing drugs are the major factors driving the growth of the real world evidence market for pharmaceutical & medical device companies.

Key Topics Covered:

1 Real World Evidence Solutions Market: Introduction

2 Real World Evidence Solutions Market: Research Methodology

3 Real World Evidence Solutions Market: Executive Summary

4 Real World Evidence Solutions Market: Premium Insights

5 Real World Evidence Solutions Market: Overview

6 Industry Trends

7 Real World Evidence Solutions Market: By Component

8 Real World Evidence Solutions Market: By Therapeutic Area

9 Real World Evidence Solutions Market: By End User

10 Real World Evidence Solutions Market: By Region

11 Competitive Landscape

12 Company Profiles

  • Anthem
  • Clinigen
  • Cognizant
  • IBM
  • Icon PLC
  • Iqvia
  • Optum (A Subsidiary of United Health Group, Inc.)
  • Oracle
  • Parexel
  • Perkinelmer
  • Pharmaceutical Product Development
  • SAS Institute
  • Syneos Health

For more information about this report visit https://www.researchandmarkets.com/research/ncrgn8/real_world?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900